nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapagliflozin—UGT1A9—Mycophenolate mofetil—systemic lupus erythematosus	0.113	0.166	CbGbCtD
Dapagliflozin—UGT2B7—Mycophenolate mofetil—systemic lupus erythematosus	0.107	0.157	CbGbCtD
Dapagliflozin—CYP2A6—Prednisolone—systemic lupus erythematosus	0.0466	0.0682	CbGbCtD
Dapagliflozin—CYP1A2—Leflunomide—systemic lupus erythematosus	0.034	0.0498	CbGbCtD
Dapagliflozin—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0306	0.0449	CbGbCtD
Dapagliflozin—CYP2A6—Dexamethasone—systemic lupus erythematosus	0.0275	0.0402	CbGbCtD
Dapagliflozin—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0242	0.0355	CbGbCtD
Dapagliflozin—CYP1A1—Dexamethasone—systemic lupus erythematosus	0.0235	0.0344	CbGbCtD
Dapagliflozin—CYP2C9—Dapsone—systemic lupus erythematosus	0.0218	0.032	CbGbCtD
Dapagliflozin—SLC5A4—urine—systemic lupus erythematosus	0.0207	0.148	CbGeAlD
Dapagliflozin—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.0184	0.0269	CbGbCtD
Dapagliflozin—ABCB1—Betamethasone—systemic lupus erythematosus	0.0158	0.0231	CbGbCtD
Dapagliflozin—SLC5A2—urine—systemic lupus erythematosus	0.0157	0.112	CbGeAlD
Dapagliflozin—ABCB1—Prednisolone—systemic lupus erythematosus	0.0155	0.0228	CbGbCtD
Dapagliflozin—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.0147	0.0216	CbGbCtD
Dapagliflozin—ABCB1—Prednisone—systemic lupus erythematosus	0.0147	0.0215	CbGbCtD
Dapagliflozin—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0145	0.0213	CbGbCtD
Dapagliflozin—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.0143	0.021	CbGbCtD
Dapagliflozin—ABCB1—Cyclosporine—systemic lupus erythematosus	0.0139	0.0204	CbGbCtD
Dapagliflozin—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.0131	0.0192	CbGbCtD
Dapagliflozin—CYP3A4—Dapsone—systemic lupus erythematosus	0.0127	0.0186	CbGbCtD
Dapagliflozin—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.011	0.0161	CbGbCtD
Dapagliflozin—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.011	0.0161	CbGbCtD
Dapagliflozin—SLC5A4—blood plasma—systemic lupus erythematosus	0.0108	0.0774	CbGeAlD
Dapagliflozin—CYP2C9—cardial valve—systemic lupus erythematosus	0.00998	0.0716	CbGeAlD
Dapagliflozin—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.00944	0.0138	CbGbCtD
Dapagliflozin—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00944	0.0138	CbGbCtD
Dapagliflozin—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00931	0.0136	CbGbCtD
Dapagliflozin—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00916	0.0134	CbGbCtD
Dapagliflozin—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00883	0.0129	CbGbCtD
Dapagliflozin—CYP3A4—Prednisone—systemic lupus erythematosus	0.00879	0.0129	CbGbCtD
Dapagliflozin—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.00863	0.0126	CbGbCtD
Dapagliflozin—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00834	0.0122	CbGbCtD
Dapagliflozin—SLC5A2—blood plasma—systemic lupus erythematosus	0.00817	0.0587	CbGeAlD
Dapagliflozin—ABCB1—Methotrexate—systemic lupus erythematosus	0.00736	0.0108	CbGbCtD
Dapagliflozin—SLC5A4—nephron tubule—systemic lupus erythematosus	0.00556	0.0399	CbGeAlD
Dapagliflozin—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00549	0.00804	CbGbCtD
Dapagliflozin—SLC5A4—kidney—systemic lupus erythematosus	0.00489	0.0351	CbGeAlD
Dapagliflozin—SLC5A11—cortex of kidney—systemic lupus erythematosus	0.00432	0.031	CbGeAlD
Dapagliflozin—SLC5A2—nephron tubule—systemic lupus erythematosus	0.00421	0.0303	CbGeAlD
Dapagliflozin—SLC5A2—kidney—systemic lupus erythematosus	0.0037	0.0266	CbGeAlD
Dapagliflozin—SLC5A2—cortex of kidney—systemic lupus erythematosus	0.00361	0.0259	CbGeAlD
Dapagliflozin—SLC5A11—tendon—systemic lupus erythematosus	0.00358	0.0257	CbGeAlD
Dapagliflozin—SLC5A4—nervous system—systemic lupus erythematosus	0.00321	0.023	CbGeAlD
Dapagliflozin—SLC5A1—nephron tubule—systemic lupus erythematosus	0.00319	0.0229	CbGeAlD
Dapagliflozin—SLC5A4—central nervous system—systemic lupus erythematosus	0.00309	0.0222	CbGeAlD
Dapagliflozin—SLC5A11—nervous system—systemic lupus erythematosus	0.00291	0.0209	CbGeAlD
Dapagliflozin—SLC5A1—kidney—systemic lupus erythematosus	0.00281	0.0202	CbGeAlD
Dapagliflozin—SLC5A11—central nervous system—systemic lupus erythematosus	0.0028	0.0201	CbGeAlD
Dapagliflozin—CYP1A2—urine—systemic lupus erythematosus	0.00227	0.0163	CbGeAlD
Dapagliflozin—CYP2C9—urine—systemic lupus erythematosus	0.00215	0.0154	CbGeAlD
Dapagliflozin—Canagliflozin—ALB—systemic lupus erythematosus	0.00213	1	CrCbGaD
Dapagliflozin—SLC5A1—lung—systemic lupus erythematosus	0.00199	0.0143	CbGeAlD
Dapagliflozin—UGT2B4—lung—systemic lupus erythematosus	0.00183	0.0132	CbGeAlD
Dapagliflozin—UGT1A9—kidney—systemic lupus erythematosus	0.00177	0.0127	CbGeAlD
Dapagliflozin—CYP3A4—urine—systemic lupus erythematosus	0.00164	0.0118	CbGeAlD
Dapagliflozin—CYP2D6—urine—systemic lupus erythematosus	0.00161	0.0116	CbGeAlD
Dapagliflozin—UGT2B7—kidney—systemic lupus erythematosus	0.00142	0.0102	CbGeAlD
Dapagliflozin—CYP1A2—blood plasma—systemic lupus erythematosus	0.00118	0.00849	CbGeAlD
Dapagliflozin—CYP2C9—blood plasma—systemic lupus erythematosus	0.00112	0.00806	CbGeAlD
Dapagliflozin—CYP3A4—blood plasma—systemic lupus erythematosus	0.000856	0.00615	CbGeAlD
Dapagliflozin—CYP2D6—blood plasma—systemic lupus erythematosus	0.000843	0.00605	CbGeAlD
Dapagliflozin—CYP2A6—lung—systemic lupus erythematosus	0.000723	0.00519	CbGeAlD
Dapagliflozin—ABCB1—blood plasma—systemic lupus erythematosus	0.000606	0.00435	CbGeAlD
Dapagliflozin—CYP1A1—skin of body—systemic lupus erythematosus	0.000561	0.00403	CbGeAlD
Dapagliflozin—CYP1A1—kidney—systemic lupus erythematosus	0.000529	0.0038	CbGeAlD
Dapagliflozin—CYP3A4—kidney—systemic lupus erythematosus	0.000388	0.00279	CbGeAlD
Dapagliflozin—CYP2D6—kidney—systemic lupus erythematosus	0.000382	0.00274	CbGeAlD
Dapagliflozin—CYP1A2—lung—systemic lupus erythematosus	0.00038	0.00273	CbGeAlD
Dapagliflozin—Influenza—Triamcinolone—systemic lupus erythematosus	0.000378	0.00268	CcSEcCtD
Dapagliflozin—Vaginal infection—Methotrexate—systemic lupus erythematosus	0.000375	0.00267	CcSEcCtD
Dapagliflozin—CYP1A1—lung—systemic lupus erythematosus	0.000375	0.00269	CbGeAlD
Dapagliflozin—Angioedema—Leflunomide—systemic lupus erythematosus	0.000372	0.00265	CcSEcCtD
Dapagliflozin—Nausea—Dapsone—systemic lupus erythematosus	0.00037	0.00263	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic lupus erythematosus	0.000365	0.00259	CcSEcCtD
Dapagliflozin—Discomfort—Azathioprine—systemic lupus erythematosus	0.000363	0.00258	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Prednisolone—systemic lupus erythematosus	0.000361	0.00257	CcSEcCtD
Dapagliflozin—Urine output increased—Methotrexate—systemic lupus erythematosus	0.00036	0.00255	CcSEcCtD
Dapagliflozin—Neoplasm—Methotrexate—systemic lupus erythematosus	0.00036	0.00255	CcSEcCtD
Dapagliflozin—Myocardial infarction—Prednisolone—systemic lupus erythematosus	0.000359	0.00255	CcSEcCtD
Dapagliflozin—Infestation NOS—Hydrocortisone—systemic lupus erythematosus	0.000358	0.00254	CcSEcCtD
Dapagliflozin—Infestation—Hydrocortisone—systemic lupus erythematosus	0.000358	0.00254	CcSEcCtD
Dapagliflozin—Urinary tract disorder—Cyclosporine—systemic lupus erythematosus	0.000357	0.00254	CcSEcCtD
Dapagliflozin—Connective tissue disorder—Cyclosporine—systemic lupus erythematosus	0.000355	0.00252	CcSEcCtD
Dapagliflozin—Urethral disorder—Cyclosporine—systemic lupus erythematosus	0.000354	0.00252	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Hydrocortisone—systemic lupus erythematosus	0.000353	0.00251	CcSEcCtD
Dapagliflozin—Hypertension—Leflunomide—systemic lupus erythematosus	0.000352	0.0025	CcSEcCtD
Dapagliflozin—Myocardial infarction—Hydrocortisone—systemic lupus erythematosus	0.000351	0.00249	CcSEcCtD
Dapagliflozin—Infection—Azathioprine—systemic lupus erythematosus	0.00035	0.00249	CcSEcCtD
Dapagliflozin—Urinary tract disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000348	0.00247	CcSEcCtD
Dapagliflozin—CYP1A1—nervous system—systemic lupus erythematosus	0.000347	0.00249	CbGeAlD
Dapagliflozin—Connective tissue disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000346	0.00246	CcSEcCtD
Dapagliflozin—Urethral disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000346	0.00246	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic lupus erythematosus	0.000345	0.00245	CcSEcCtD
Dapagliflozin—Discomfort—Leflunomide—systemic lupus erythematosus	0.000343	0.00244	CcSEcCtD
Dapagliflozin—Skin disorder—Azathioprine—systemic lupus erythematosus	0.000342	0.00243	CcSEcCtD
Dapagliflozin—Infestation—Methylprednisolone—systemic lupus erythematosus	0.000336	0.00239	CcSEcCtD
Dapagliflozin—Infestation NOS—Methylprednisolone—systemic lupus erythematosus	0.000336	0.00239	CcSEcCtD
Dapagliflozin—CYP1A1—central nervous system—systemic lupus erythematosus	0.000334	0.0024	CbGeAlD
Dapagliflozin—Anaphylactic shock—Leflunomide—systemic lupus erythematosus	0.000333	0.00236	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Triamcinolone—systemic lupus erythematosus	0.000332	0.00236	CcSEcCtD
Dapagliflozin—Diabetes mellitus—Methotrexate—systemic lupus erythematosus	0.000332	0.00236	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Methylprednisolone—systemic lupus erythematosus	0.000331	0.00235	CcSEcCtD
Dapagliflozin—Infection—Leflunomide—systemic lupus erythematosus	0.00033	0.00235	CcSEcCtD
Dapagliflozin—Myocardial infarction—Triamcinolone—systemic lupus erythematosus	0.00033	0.00235	CcSEcCtD
Dapagliflozin—Myocardial infarction—Methylprednisolone—systemic lupus erythematosus	0.000329	0.00234	CcSEcCtD
Dapagliflozin—Hypotension—Azathioprine—systemic lupus erythematosus	0.000329	0.00234	CcSEcCtD
Dapagliflozin—Polyuria—Methotrexate—systemic lupus erythematosus	0.000329	0.00234	CcSEcCtD
Dapagliflozin—Skin disorder—Leflunomide—systemic lupus erythematosus	0.000323	0.0023	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Leflunomide—systemic lupus erythematosus	0.000322	0.00228	CcSEcCtD
Dapagliflozin—Connective tissue disorder—Hydrocortisone—systemic lupus erythematosus	0.000316	0.00224	CcSEcCtD
Dapagliflozin—Malnutrition—Cyclosporine—systemic lupus erythematosus	0.000315	0.00223	CcSEcCtD
Dapagliflozin—ABCB1—nephron tubule—systemic lupus erythematosus	0.000313	0.00224	CbGeAlD
Dapagliflozin—Hypotension—Leflunomide—systemic lupus erythematosus	0.000311	0.00221	CcSEcCtD
Dapagliflozin—Malnutrition—Mycophenolate mofetil—systemic lupus erythematosus	0.000307	0.00218	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Azathioprine—systemic lupus erythematosus	0.000304	0.00216	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Betamethasone—systemic lupus erythematosus	0.000301	0.00214	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Dexamethasone—systemic lupus erythematosus	0.000301	0.00214	CcSEcCtD
Dapagliflozin—Myocardial infarction—Dexamethasone—systemic lupus erythematosus	0.0003	0.00213	CcSEcCtD
Dapagliflozin—Myocardial infarction—Betamethasone—systemic lupus erythematosus	0.0003	0.00213	CcSEcCtD
Dapagliflozin—Back pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000297	0.00211	CcSEcCtD
Dapagliflozin—Connective tissue disorder—Methylprednisolone—systemic lupus erythematosus	0.000296	0.00211	CcSEcCtD
Dapagliflozin—Cerebrovascular accident—Methotrexate—systemic lupus erythematosus	0.000295	0.00209	CcSEcCtD
Dapagliflozin—Angioedema—Cyclosporine—systemic lupus erythematosus	0.000287	0.00204	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Leflunomide—systemic lupus erythematosus	0.000287	0.00204	CcSEcCtD
Dapagliflozin—Constipation—Leflunomide—systemic lupus erythematosus	0.000284	0.00202	CcSEcCtD
Dapagliflozin—Angioedema—Mycophenolate mofetil—systemic lupus erythematosus	0.00028	0.00199	CcSEcCtD
Dapagliflozin—Malnutrition—Hydrocortisone—systemic lupus erythematosus	0.00028	0.00199	CcSEcCtD
Dapagliflozin—Body temperature increased—Azathioprine—systemic lupus erythematosus	0.000278	0.00198	CcSEcCtD
Dapagliflozin—ABCB1—kidney—systemic lupus erythematosus	0.000275	0.00197	CbGeAlD
Dapagliflozin—Hypertension—Cyclosporine—systemic lupus erythematosus	0.000272	0.00193	CcSEcCtD
Dapagliflozin—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000268	0.00192	CbGeAlD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—systemic lupus erythematosus	0.000266	0.00189	CcSEcCtD
Dapagliflozin—Hypertension—Mycophenolate mofetil—systemic lupus erythematosus	0.000265	0.00188	CcSEcCtD
Dapagliflozin—Discomfort—Cyclosporine—systemic lupus erythematosus	0.000265	0.00188	CcSEcCtD
Dapagliflozin—Urticaria—Leflunomide—systemic lupus erythematosus	0.000264	0.00188	CcSEcCtD
Dapagliflozin—Body temperature increased—Leflunomide—systemic lupus erythematosus	0.000263	0.00187	CcSEcCtD
Dapagliflozin—Malnutrition—Methylprednisolone—systemic lupus erythematosus	0.000263	0.00187	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Prednisone—systemic lupus erythematosus	0.000262	0.00186	CcSEcCtD
Dapagliflozin—Angioedema—Prednisolone—systemic lupus erythematosus	0.000262	0.00186	CcSEcCtD
Dapagliflozin—Myocardial infarction—Prednisone—systemic lupus erythematosus	0.000261	0.00185	CcSEcCtD
Dapagliflozin—Hypersensitivity—Azathioprine—systemic lupus erythematosus	0.00026	0.00184	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic lupus erythematosus	0.000259	0.00184	CcSEcCtD
Dapagliflozin—Discomfort—Mycophenolate mofetil—systemic lupus erythematosus	0.000258	0.00183	CcSEcCtD
Dapagliflozin—Oedema—Cyclosporine—systemic lupus erythematosus	0.000257	0.00182	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Cyclosporine—systemic lupus erythematosus	0.000257	0.00182	CcSEcCtD
Dapagliflozin—Angioedema—Hydrocortisone—systemic lupus erythematosus	0.000255	0.00181	CcSEcCtD
Dapagliflozin—Infection—Cyclosporine—systemic lupus erythematosus	0.000255	0.00181	CcSEcCtD
Dapagliflozin—CYP3A4—nervous system—systemic lupus erythematosus	0.000255	0.00183	CbGeAlD
Dapagliflozin—Back pain—Triamcinolone—systemic lupus erythematosus	0.000255	0.00181	CcSEcCtD
Dapagliflozin—CYP2D6—nervous system—systemic lupus erythematosus	0.000251	0.0018	CbGeAlD
Dapagliflozin—Anaphylactic shock—Mycophenolate mofetil—systemic lupus erythematosus	0.00025	0.00178	CcSEcCtD
Dapagliflozin—Oedema—Mycophenolate mofetil—systemic lupus erythematosus	0.00025	0.00178	CcSEcCtD
Dapagliflozin—Skin disorder—Cyclosporine—systemic lupus erythematosus	0.000249	0.00177	CcSEcCtD
Dapagliflozin—Infection—Mycophenolate mofetil—systemic lupus erythematosus	0.000249	0.00177	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Cyclosporine—systemic lupus erythematosus	0.000248	0.00176	CcSEcCtD
Dapagliflozin—Hypertension—Prednisolone—systemic lupus erythematosus	0.000247	0.00176	CcSEcCtD
Dapagliflozin—CYP3A4—central nervous system—systemic lupus erythematosus	0.000245	0.00176	CbGeAlD
Dapagliflozin—Hypersensitivity—Leflunomide—systemic lupus erythematosus	0.000245	0.00174	CcSEcCtD
Dapagliflozin—Skin disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000243	0.00173	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Mycophenolate mofetil—systemic lupus erythematosus	0.000242	0.00172	CcSEcCtD
Dapagliflozin—Hypertension—Hydrocortisone—systemic lupus erythematosus	0.000241	0.00171	CcSEcCtD
Dapagliflozin—CYP2D6—central nervous system—systemic lupus erythematosus	0.000241	0.00173	CbGeAlD
Dapagliflozin—Discomfort—Prednisolone—systemic lupus erythematosus	0.000241	0.00171	CcSEcCtD
Dapagliflozin—Angioedema—Triamcinolone—systemic lupus erythematosus	0.000241	0.00171	CcSEcCtD
Dapagliflozin—Angioedema—Methylprednisolone—systemic lupus erythematosus	0.00024	0.00171	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—systemic lupus erythematosus	0.000236	0.00168	CcSEcCtD
Dapagliflozin—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000236	0.00169	CbGeAlD
Dapagliflozin—Discomfort—Hydrocortisone—systemic lupus erythematosus	0.000235	0.00167	CcSEcCtD
Dapagliflozin—Connective tissue disorder—Prednisone—systemic lupus erythematosus	0.000235	0.00167	CcSEcCtD
Dapagliflozin—Hypotension—Mycophenolate mofetil—systemic lupus erythematosus	0.000234	0.00166	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Prednisolone—systemic lupus erythematosus	0.000234	0.00166	CcSEcCtD
Dapagliflozin—Oedema—Prednisolone—systemic lupus erythematosus	0.000234	0.00166	CcSEcCtD
Dapagliflozin—Dysuria—Methotrexate—systemic lupus erythematosus	0.000233	0.00166	CcSEcCtD
Dapagliflozin—Dizziness—Azathioprine—systemic lupus erythematosus	0.000233	0.00165	CcSEcCtD
Dapagliflozin—Oedema—Hydrocortisone—systemic lupus erythematosus	0.000228	0.00162	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Hydrocortisone—systemic lupus erythematosus	0.000228	0.00162	CcSEcCtD
Dapagliflozin—Hypertension—Triamcinolone—systemic lupus erythematosus	0.000227	0.00161	CcSEcCtD
Dapagliflozin—Hypertension—Methylprednisolone—systemic lupus erythematosus	0.000227	0.00161	CcSEcCtD
Dapagliflozin—Infection—Hydrocortisone—systemic lupus erythematosus	0.000227	0.00161	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Prednisolone—systemic lupus erythematosus	0.000226	0.0016	CcSEcCtD
Dapagliflozin—Infestation—Methotrexate—systemic lupus erythematosus	0.000222	0.00158	CcSEcCtD
Dapagliflozin—Infestation NOS—Methotrexate—systemic lupus erythematosus	0.000222	0.00158	CcSEcCtD
Dapagliflozin—Rash—Azathioprine—systemic lupus erythematosus	0.000222	0.00158	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	0.000222	0.00158	CcSEcCtD
Dapagliflozin—Dermatitis—Azathioprine—systemic lupus erythematosus	0.000222	0.00158	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.000222	0.00157	CcSEcCtD
Dapagliflozin—Skin disorder—Hydrocortisone—systemic lupus erythematosus	0.000222	0.00157	CcSEcCtD
Dapagliflozin—Discomfort—Triamcinolone—systemic lupus erythematosus	0.000221	0.00157	CcSEcCtD
Dapagliflozin—Discomfort—Methylprednisolone—systemic lupus erythematosus	0.000221	0.00157	CcSEcCtD
Dapagliflozin—Headache—Azathioprine—systemic lupus erythematosus	0.000221	0.00157	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Hydrocortisone—systemic lupus erythematosus	0.000221	0.00157	CcSEcCtD
Dapagliflozin—Dizziness—Leflunomide—systemic lupus erythematosus	0.00022	0.00156	CcSEcCtD
Dapagliflozin—Constipation—Cyclosporine—systemic lupus erythematosus	0.00022	0.00156	CcSEcCtD
Dapagliflozin—Renal failure—Methotrexate—systemic lupus erythematosus	0.000219	0.00155	CcSEcCtD
Dapagliflozin—Angioedema—Dexamethasone—systemic lupus erythematosus	0.000218	0.00155	CcSEcCtD
Dapagliflozin—Angioedema—Betamethasone—systemic lupus erythematosus	0.000218	0.00155	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000216	0.00154	CcSEcCtD
Dapagliflozin—ABCB1—bone marrow—systemic lupus erythematosus	0.000215	0.00154	CbGeAlD
Dapagliflozin—Oedema—Triamcinolone—systemic lupus erythematosus	0.000215	0.00153	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Triamcinolone—systemic lupus erythematosus	0.000215	0.00153	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Methylprednisolone—systemic lupus erythematosus	0.000214	0.00152	CcSEcCtD
Dapagliflozin—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	0.000214	0.00152	CcSEcCtD
Dapagliflozin—Infection—Triamcinolone—systemic lupus erythematosus	0.000213	0.00152	CcSEcCtD
Dapagliflozin—Hypotension—Hydrocortisone—systemic lupus erythematosus	0.000213	0.00151	CcSEcCtD
Dapagliflozin—Infection—Methylprednisolone—systemic lupus erythematosus	0.000213	0.00151	CcSEcCtD
Dapagliflozin—Rash—Leflunomide—systemic lupus erythematosus	0.00021	0.00149	CcSEcCtD
Dapagliflozin—Dermatitis—Leflunomide—systemic lupus erythematosus	0.00021	0.00149	CcSEcCtD
Dapagliflozin—Nausea—Azathioprine—systemic lupus erythematosus	0.000209	0.00149	CcSEcCtD
Dapagliflozin—Headache—Leflunomide—systemic lupus erythematosus	0.000208	0.00148	CcSEcCtD
Dapagliflozin—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000208	0.00148	CcSEcCtD
Dapagliflozin—Malnutrition—Prednisone—systemic lupus erythematosus	0.000208	0.00148	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	0.000208	0.00148	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	0.000207	0.00147	CcSEcCtD
Dapagliflozin—Hypertension—Dexamethasone—systemic lupus erythematosus	0.000206	0.00147	CcSEcCtD
Dapagliflozin—Hypertension—Betamethasone—systemic lupus erythematosus	0.000206	0.00147	CcSEcCtD
Dapagliflozin—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000204	0.00145	CcSEcCtD
Dapagliflozin—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000203	0.00144	CcSEcCtD
Dapagliflozin—Discomfort—Betamethasone—systemic lupus erythematosus	0.000201	0.00143	CcSEcCtD
Dapagliflozin—Discomfort—Dexamethasone—systemic lupus erythematosus	0.000201	0.00143	CcSEcCtD
Dapagliflozin—Hypotension—Methylprednisolone—systemic lupus erythematosus	0.0002	0.00142	CcSEcCtD
Dapagliflozin—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000199	0.00141	CcSEcCtD
Dapagliflozin—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000198	0.00141	CcSEcCtD
Dapagliflozin—Nausea—Leflunomide—systemic lupus erythematosus	0.000198	0.0014	CcSEcCtD
Dapagliflozin—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	0.000197	0.0014	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000197	0.0014	CcSEcCtD
Dapagliflozin—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.000196	0.00139	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	0.000195	0.00138	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	0.000195	0.00138	CcSEcCtD
Dapagliflozin—Oedema—Dexamethasone—systemic lupus erythematosus	0.000195	0.00138	CcSEcCtD
Dapagliflozin—Oedema—Betamethasone—systemic lupus erythematosus	0.000195	0.00138	CcSEcCtD
Dapagliflozin—ABCB1—lung—systemic lupus erythematosus	0.000195	0.0014	CbGeAlD
Dapagliflozin—Infection—Betamethasone—systemic lupus erythematosus	0.000194	0.00138	CcSEcCtD
Dapagliflozin—Infection—Dexamethasone—systemic lupus erythematosus	0.000194	0.00138	CcSEcCtD
Dapagliflozin—Angioedema—Prednisone—systemic lupus erythematosus	0.00019	0.00135	CcSEcCtD
Dapagliflozin—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000189	0.00134	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	0.000188	0.00134	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	0.000188	0.00134	CcSEcCtD
Dapagliflozin—Urticaria—Prednisolone—systemic lupus erythematosus	0.000186	0.00132	CcSEcCtD
Dapagliflozin—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000185	0.00131	CcSEcCtD
Dapagliflozin—Hypotension—Betamethasone—systemic lupus erythematosus	0.000182	0.00129	CcSEcCtD
Dapagliflozin—Hypotension—Dexamethasone—systemic lupus erythematosus	0.000182	0.00129	CcSEcCtD
Dapagliflozin—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000181	0.00129	CcSEcCtD
Dapagliflozin—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.00018	0.00128	CcSEcCtD
Dapagliflozin—ABCB1—nervous system—systemic lupus erythematosus	0.00018	0.00129	CbGeAlD
Dapagliflozin—Hypertension—Prednisone—systemic lupus erythematosus	0.00018	0.00128	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000176	0.00125	CcSEcCtD
Dapagliflozin—Discomfort—Prednisone—systemic lupus erythematosus	0.000175	0.00124	CcSEcCtD
Dapagliflozin—Malnutrition—Methotrexate—systemic lupus erythematosus	0.000174	0.00124	CcSEcCtD
Dapagliflozin—ABCB1—central nervous system—systemic lupus erythematosus	0.000174	0.00125	CbGeAlD
Dapagliflozin—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000172	0.00122	CcSEcCtD
Dapagliflozin—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000171	0.00121	CcSEcCtD
Dapagliflozin—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.00017	0.00121	CcSEcCtD
Dapagliflozin—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.00017	0.00121	CcSEcCtD
Dapagliflozin—Dizziness—Cyclosporine—systemic lupus erythematosus	0.00017	0.00121	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Prednisone—systemic lupus erythematosus	0.00017	0.00121	CcSEcCtD
Dapagliflozin—Oedema—Prednisone—systemic lupus erythematosus	0.00017	0.00121	CcSEcCtD
Dapagliflozin—Infection—Prednisone—systemic lupus erythematosus	0.000169	0.0012	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000168	0.0012	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000168	0.0012	CcSEcCtD
Dapagliflozin—Back pain—Methotrexate—systemic lupus erythematosus	0.000168	0.00119	CcSEcCtD
Dapagliflozin—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000168	0.00119	CcSEcCtD
Dapagliflozin—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000166	0.00118	CcSEcCtD
Dapagliflozin—Skin disorder—Prednisone—systemic lupus erythematosus	0.000165	0.00117	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Prednisone—systemic lupus erythematosus	0.000164	0.00117	CcSEcCtD
Dapagliflozin—Rash—Cyclosporine—systemic lupus erythematosus	0.000162	0.00115	CcSEcCtD
Dapagliflozin—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000162	0.00115	CcSEcCtD
Dapagliflozin—Headache—Cyclosporine—systemic lupus erythematosus	0.000161	0.00114	CcSEcCtD
Dapagliflozin—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000158	0.00112	CcSEcCtD
Dapagliflozin—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000158	0.00112	CcSEcCtD
Dapagliflozin—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000158	0.00112	CcSEcCtD
Dapagliflozin—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000158	0.00112	CcSEcCtD
Dapagliflozin—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000157	0.00111	CcSEcCtD
Dapagliflozin—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000155	0.0011	CcSEcCtD
Dapagliflozin—Urticaria—Betamethasone—systemic lupus erythematosus	0.000155	0.0011	CcSEcCtD
Dapagliflozin—Dizziness—Prednisolone—systemic lupus erythematosus	0.000154	0.0011	CcSEcCtD
Dapagliflozin—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000154	0.00109	CcSEcCtD
Dapagliflozin—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000154	0.00109	CcSEcCtD
Dapagliflozin—Nausea—Cyclosporine—systemic lupus erythematosus	0.000152	0.00108	CcSEcCtD
Dapagliflozin—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000151	0.00107	CcSEcCtD
Dapagliflozin—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000149	0.00106	CcSEcCtD
Dapagliflozin—Rash—Prednisolone—systemic lupus erythematosus	0.000147	0.00105	CcSEcCtD
Dapagliflozin—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000147	0.00105	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.000147	0.00104	CcSEcCtD
Dapagliflozin—Headache—Prednisolone—systemic lupus erythematosus	0.000146	0.00104	CcSEcCtD
Dapagliflozin—Discomfort—Methotrexate—systemic lupus erythematosus	0.000146	0.00104	CcSEcCtD
Dapagliflozin—Constipation—Prednisone—systemic lupus erythematosus	0.000145	0.00103	CcSEcCtD
Dapagliflozin—Rash—Hydrocortisone—systemic lupus erythematosus	0.000144	0.00102	CcSEcCtD
Dapagliflozin—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000144	0.00102	CcSEcCtD
Dapagliflozin—Headache—Hydrocortisone—systemic lupus erythematosus	0.000143	0.00102	CcSEcCtD
Dapagliflozin—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000142	0.00101	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	0.000142	0.00101	CcSEcCtD
Dapagliflozin—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000142	0.00101	CcSEcCtD
Dapagliflozin—Infection—Methotrexate—systemic lupus erythematosus	0.000141	0.001	CcSEcCtD
Dapagliflozin—Nausea—Prednisolone—systemic lupus erythematosus	0.000139	0.000986	CcSEcCtD
Dapagliflozin—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000138	0.000979	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	0.000137	0.000974	CcSEcCtD
Dapagliflozin—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000136	0.000963	CcSEcCtD
Dapagliflozin—Rash—Triamcinolone—systemic lupus erythematosus	0.000135	0.000962	CcSEcCtD
Dapagliflozin—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000135	0.000962	CcSEcCtD
Dapagliflozin—Rash—Methylprednisolone—systemic lupus erythematosus	0.000135	0.00096	CcSEcCtD
Dapagliflozin—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000135	0.000959	CcSEcCtD
Dapagliflozin—Urticaria—Prednisone—systemic lupus erythematosus	0.000135	0.000958	CcSEcCtD
Dapagliflozin—Headache—Triamcinolone—systemic lupus erythematosus	0.000135	0.000956	CcSEcCtD
Dapagliflozin—Headache—Methylprednisolone—systemic lupus erythematosus	0.000134	0.000954	CcSEcCtD
Dapagliflozin—Body temperature increased—Prednisone—systemic lupus erythematosus	0.000134	0.000953	CcSEcCtD
Dapagliflozin—Hypotension—Methotrexate—systemic lupus erythematosus	0.000133	0.000942	CcSEcCtD
Dapagliflozin—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000129	0.000916	CcSEcCtD
Dapagliflozin—Dizziness—Betamethasone—systemic lupus erythematosus	0.000129	0.000916	CcSEcCtD
Dapagliflozin—Nausea—Triamcinolone—systemic lupus erythematosus	0.000128	0.000907	CcSEcCtD
Dapagliflozin—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000127	0.000905	CcSEcCtD
Dapagliflozin—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.000125	0.000889	CcSEcCtD
Dapagliflozin—Rash—Dexamethasone—systemic lupus erythematosus	0.000123	0.000873	CcSEcCtD
Dapagliflozin—Rash—Betamethasone—systemic lupus erythematosus	0.000123	0.000873	CcSEcCtD
Dapagliflozin—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000123	0.000872	CcSEcCtD
Dapagliflozin—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000123	0.000872	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.000122	0.00087	CcSEcCtD
Dapagliflozin—Headache—Betamethasone—systemic lupus erythematosus	0.000122	0.000868	CcSEcCtD
Dapagliflozin—Headache—Dexamethasone—systemic lupus erythematosus	0.000122	0.000868	CcSEcCtD
Dapagliflozin—Nausea—Dexamethasone—systemic lupus erythematosus	0.000116	0.000823	CcSEcCtD
Dapagliflozin—Nausea—Betamethasone—systemic lupus erythematosus	0.000116	0.000823	CcSEcCtD
Dapagliflozin—Urticaria—Methotrexate—systemic lupus erythematosus	0.000113	0.000801	CcSEcCtD
Dapagliflozin—Dizziness—Prednisone—systemic lupus erythematosus	0.000112	0.000798	CcSEcCtD
Dapagliflozin—Body temperature increased—Methotrexate—systemic lupus erythematosus	0.000112	0.000797	CcSEcCtD
Dapagliflozin—Rash—Prednisone—systemic lupus erythematosus	0.000107	0.00076	CcSEcCtD
Dapagliflozin—Dermatitis—Prednisone—systemic lupus erythematosus	0.000107	0.00076	CcSEcCtD
Dapagliflozin—Headache—Prednisone—systemic lupus erythematosus	0.000106	0.000756	CcSEcCtD
Dapagliflozin—Hypersensitivity—Methotrexate—systemic lupus erythematosus	0.000105	0.000743	CcSEcCtD
Dapagliflozin—Nausea—Prednisone—systemic lupus erythematosus	0.000101	0.000716	CcSEcCtD
Dapagliflozin—Dizziness—Methotrexate—systemic lupus erythematosus	9.38e-05	0.000667	CcSEcCtD
Dapagliflozin—Rash—Methotrexate—systemic lupus erythematosus	8.95e-05	0.000636	CcSEcCtD
Dapagliflozin—Dermatitis—Methotrexate—systemic lupus erythematosus	8.94e-05	0.000635	CcSEcCtD
Dapagliflozin—Headache—Methotrexate—systemic lupus erythematosus	8.89e-05	0.000631	CcSEcCtD
Dapagliflozin—Nausea—Methotrexate—systemic lupus erythematosus	8.43e-05	0.000599	CcSEcCtD
Dapagliflozin—CYP2A6—NRF2 pathway—RXRA—systemic lupus erythematosus	7.04e-05	0.00199	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—systemic lupus erythematosus	6.84e-05	0.00194	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—HLA-DQA1—systemic lupus erythematosus	6.83e-05	0.00193	CbGpPWpGaD
Dapagliflozin—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	6.81e-05	0.00193	CbGpPWpGaD
Dapagliflozin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	6.77e-05	0.00192	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—NAT2—systemic lupus erythematosus	6.6e-05	0.00187	CbGpPWpGaD
Dapagliflozin—CYP1A1—PPARA activates gene expression—RXRA—systemic lupus erythematosus	6.58e-05	0.00186	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—systemic lupus erythematosus	6.56e-05	0.00186	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—JUNB—systemic lupus erythematosus	6.53e-05	0.00185	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—JUNB—systemic lupus erythematosus	6.53e-05	0.00185	CbGpPWpGaD
Dapagliflozin—CYP2D6—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	6.52e-05	0.00184	CbGpPWpGaD
Dapagliflozin—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	6.46e-05	0.00183	CbGpPWpGaD
Dapagliflozin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—systemic lupus erythematosus	6.44e-05	0.00182	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—HLA-DQB1—systemic lupus erythematosus	6.39e-05	0.00181	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—JAK1—systemic lupus erythematosus	6.35e-05	0.0018	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—RXRA—systemic lupus erythematosus	6.32e-05	0.00179	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—systemic lupus erythematosus	6.22e-05	0.00176	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	6.22e-05	0.00176	CbGpPWpGaD
Dapagliflozin—CYP2D6—Biological oxidations—NAT2—systemic lupus erythematosus	6.18e-05	0.00175	CbGpPWpGaD
Dapagliflozin—CYP2A6—Biological oxidations—RXRA—systemic lupus erythematosus	6.17e-05	0.00175	CbGpPWpGaD
Dapagliflozin—CYP1A1—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	6.14e-05	0.00174	CbGpPWpGaD
Dapagliflozin—CYP2C9—Biological oxidations—NAT2—systemic lupus erythematosus	6.12e-05	0.00173	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metapathway biotransformation—NAT2—systemic lupus erythematosus	6.09e-05	0.00172	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	6.08e-05	0.00172	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metapathway biotransformation—NAT2—systemic lupus erythematosus	6.04e-05	0.00171	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—CD40LG—systemic lupus erythematosus	6.03e-05	0.00171	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—IL10—systemic lupus erythematosus	6.03e-05	0.00171	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—CCR5—systemic lupus erythematosus	6.02e-05	0.0017	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—PRL—systemic lupus erythematosus	6.02e-05	0.0017	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—PRL—systemic lupus erythematosus	6.02e-05	0.0017	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—IL4—systemic lupus erythematosus	5.87e-05	0.00166	CbGpPWpGaD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	5.81e-05	0.00164	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	5.81e-05	0.00164	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	5.74e-05	0.00162	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—FASLG—systemic lupus erythematosus	5.61e-05	0.00159	CbGpPWpGaD
Dapagliflozin—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	5.52e-05	0.00156	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	5.46e-05	0.00154	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	5.46e-05	0.00154	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—FAS—systemic lupus erythematosus	5.41e-05	0.00153	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—IL2RA—systemic lupus erythematosus	5.38e-05	0.00152	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—C3—systemic lupus erythematosus	5.33e-05	0.00151	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	5.27e-05	0.00149	CbGpPWpGaD
Dapagliflozin—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	5.26e-05	0.00149	CbGpPWpGaD
Dapagliflozin—CYP1A2—Biological oxidations—NAT2—systemic lupus erythematosus	5.23e-05	0.00148	CbGpPWpGaD
Dapagliflozin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	5.23e-05	0.00148	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	5.17e-05	0.00146	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metapathway biotransformation—NAT2—systemic lupus erythematosus	5.16e-05	0.00146	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—CD80—systemic lupus erythematosus	4.95e-05	0.0014	CbGpPWpGaD
Dapagliflozin—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—systemic lupus erythematosus	4.88e-05	0.00138	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—HLA-DRB1—systemic lupus erythematosus	4.86e-05	0.00137	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—JAK1—systemic lupus erythematosus	4.81e-05	0.00136	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—JAK1—systemic lupus erythematosus	4.81e-05	0.00136	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—RXRA—systemic lupus erythematosus	4.79e-05	0.00136	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—RXRA—systemic lupus erythematosus	4.79e-05	0.00136	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	4.74e-05	0.00134	CbGpPWpGaD
Dapagliflozin—UGT1A9—PPARA activates gene expression—EP300—systemic lupus erythematosus	4.73e-05	0.00134	CbGpPWpGaD
Dapagliflozin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—systemic lupus erythematosus	4.72e-05	0.00134	CbGpPWpGaD
Dapagliflozin—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—systemic lupus erythematosus	4.63e-05	0.00131	CbGpPWpGaD
Dapagliflozin—CYP1A1—Biological oxidations—RXRA—systemic lupus erythematosus	4.6e-05	0.0013	CbGpPWpGaD
Dapagliflozin—CYP2C9—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	4.58e-05	0.0013	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—CCR5—systemic lupus erythematosus	4.56e-05	0.00129	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—CCR5—systemic lupus erythematosus	4.56e-05	0.00129	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—CD80—systemic lupus erythematosus	4.49e-05	0.00127	CbGpPWpGaD
Dapagliflozin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—systemic lupus erythematosus	4.44e-05	0.00126	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	4.43e-05	0.00125	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	4.43e-05	0.00125	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—systemic lupus erythematosus	4.36e-05	0.00124	CbGpPWpGaD
Dapagliflozin—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	4.26e-05	0.00121	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—systemic lupus erythematosus	4.18e-05	0.00118	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—TYK2—systemic lupus erythematosus	4.18e-05	0.00118	CbGpPWpGaD
Dapagliflozin—CYP1A1—PPARA activates gene expression—PPARG—systemic lupus erythematosus	4.15e-05	0.00118	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—NOS3—systemic lupus erythematosus	4.1e-05	0.00116	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	4.09e-05	0.00116	CbGpPWpGaD
Dapagliflozin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—systemic lupus erythematosus	4.06e-05	0.00115	CbGpPWpGaD
Dapagliflozin—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	4.04e-05	0.00114	CbGpPWpGaD
Dapagliflozin—UGT2B7—NRF2 pathway—TGFB1—systemic lupus erythematosus	4.04e-05	0.00114	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—PPARG—systemic lupus erythematosus	3.99e-05	0.00113	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	3.98e-05	0.00113	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—systemic lupus erythematosus	3.96e-05	0.00112	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	3.96e-05	0.00112	CbGpPWpGaD
Dapagliflozin—CYP1A2—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	3.91e-05	0.00111	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	3.88e-05	0.0011	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	3.86e-05	0.00109	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—CD4—systemic lupus erythematosus	3.78e-05	0.00107	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—PTGS2—systemic lupus erythematosus	3.75e-05	0.00106	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—CD80—systemic lupus erythematosus	3.75e-05	0.00106	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—CD80—systemic lupus erythematosus	3.75e-05	0.00106	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—RXRA—systemic lupus erythematosus	3.7e-05	0.00105	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	3.66e-05	0.00104	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—ALB—systemic lupus erythematosus	3.59e-05	0.00102	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—CDKN1B—systemic lupus erythematosus	3.55e-05	0.00101	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—IFNG—systemic lupus erythematosus	3.55e-05	0.001	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	3.48e-05	0.000985	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	3.48e-05	0.000985	CbGpPWpGaD
Dapagliflozin—CYP2D6—Biological oxidations—RXRA—systemic lupus erythematosus	3.46e-05	0.00098	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—NOS3—systemic lupus erythematosus	3.43e-05	0.000972	CbGpPWpGaD
Dapagliflozin—CYP2C9—Biological oxidations—RXRA—systemic lupus erythematosus	3.43e-05	0.000972	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	3.38e-05	0.000956	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	3.3e-05	0.000933	CbGpPWpGaD
Dapagliflozin—UGT1A9—NRF2 pathway—TGFB1—systemic lupus erythematosus	3.28e-05	0.000928	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—CDKN1A—systemic lupus erythematosus	3.28e-05	0.000928	CbGpPWpGaD
Dapagliflozin—ABCB1—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	3.27e-05	0.000924	CbGpPWpGaD
Dapagliflozin—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—systemic lupus erythematosus	3.19e-05	0.000903	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—TYK2—systemic lupus erythematosus	3.17e-05	0.000896	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—TYK2—systemic lupus erythematosus	3.17e-05	0.000896	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—IL2—systemic lupus erythematosus	3.15e-05	0.000892	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—PTGS2—systemic lupus erythematosus	3.14e-05	0.000889	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—EP300—systemic lupus erythematosus	3.12e-05	0.000883	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—NOS3—systemic lupus erythematosus	3.11e-05	0.00088	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—NOS3—systemic lupus erythematosus	3.11e-05	0.00088	CbGpPWpGaD
Dapagliflozin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	3.09e-05	0.000876	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	3.08e-05	0.000871	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—PPARG—systemic lupus erythematosus	3.03e-05	0.000857	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—PPARG—systemic lupus erythematosus	3.03e-05	0.000857	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	3.03e-05	0.000856	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—NAT2—systemic lupus erythematosus	3.01e-05	0.000851	CbGpPWpGaD
Dapagliflozin—CYP1A2—Biological oxidations—RXRA—systemic lupus erythematosus	2.93e-05	0.00083	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—CD4—systemic lupus erythematosus	2.86e-05	0.000811	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—CD4—systemic lupus erythematosus	2.86e-05	0.000811	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—PTGS2—systemic lupus erythematosus	2.84e-05	0.000805	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—PTGS2—systemic lupus erythematosus	2.84e-05	0.000805	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	2.82e-05	0.0008	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	2.82e-05	0.0008	CbGpPWpGaD
Dapagliflozin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—systemic lupus erythematosus	2.8e-05	0.000793	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	2.77e-05	0.000783	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—ALB—systemic lupus erythematosus	2.72e-05	0.00077	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—ALB—systemic lupus erythematosus	2.72e-05	0.00077	CbGpPWpGaD
Dapagliflozin—CYP1A1—PPARA activates gene expression—EP300—systemic lupus erythematosus	2.72e-05	0.000769	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—TGFB1—systemic lupus erythematosus	2.71e-05	0.000768	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—CDKN1B—systemic lupus erythematosus	2.69e-05	0.000762	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—CDKN1B—systemic lupus erythematosus	2.69e-05	0.000762	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—VEGFA—systemic lupus erythematosus	2.68e-05	0.000758	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	2.67e-05	0.000755	CbGpPWpGaD
Dapagliflozin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—systemic lupus erythematosus	2.66e-05	0.000753	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—EP300—systemic lupus erythematosus	2.61e-05	0.00074	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—NOS3—systemic lupus erythematosus	2.6e-05	0.000737	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—NOS3—systemic lupus erythematosus	2.6e-05	0.000737	CbGpPWpGaD
Dapagliflozin—CYP2A6—NRF2 pathway—TGFB1—systemic lupus erythematosus	2.53e-05	0.000715	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—CDKN1A—systemic lupus erythematosus	2.48e-05	0.000703	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—CDKN1A—systemic lupus erythematosus	2.48e-05	0.000703	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—TGFB1—systemic lupus erythematosus	2.46e-05	0.000696	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—NAT2—systemic lupus erythematosus	2.44e-05	0.000692	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—PTGS2—systemic lupus erythematosus	2.38e-05	0.000674	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—PTGS2—systemic lupus erythematosus	2.38e-05	0.000674	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—EP300—systemic lupus erythematosus	2.36e-05	0.000669	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—EP300—systemic lupus erythematosus	2.36e-05	0.000669	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—PPARG—systemic lupus erythematosus	2.34e-05	0.000661	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—TNF—systemic lupus erythematosus	2.3e-05	0.00065	CbGpPWpGaD
Dapagliflozin—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	2.26e-05	0.000641	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—ALB—systemic lupus erythematosus	2.1e-05	0.000595	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—TGFB1—systemic lupus erythematosus	2.06e-05	0.000582	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—TGFB1—systemic lupus erythematosus	2.06e-05	0.000582	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—IL6—systemic lupus erythematosus	2.04e-05	0.000578	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—NOS3—systemic lupus erythematosus	2.01e-05	0.000569	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—EP300—systemic lupus erythematosus	1.98e-05	0.00056	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—EP300—systemic lupus erythematosus	1.98e-05	0.00056	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.94e-05	0.00055	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—NAT2—systemic lupus erythematosus	1.88e-05	0.000533	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—PTGS2—systemic lupus erythematosus	1.84e-05	0.00052	CbGpPWpGaD
Dapagliflozin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—systemic lupus erythematosus	1.83e-05	0.000519	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.77e-05	0.0005	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.75e-05	0.000494	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—RXRA—systemic lupus erythematosus	1.69e-05	0.000477	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	1.68e-05	0.000475	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	1.59e-05	0.00045	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—IL6—systemic lupus erythematosus	1.55e-05	0.000438	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—IL6—systemic lupus erythematosus	1.55e-05	0.000438	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—EP300—systemic lupus erythematosus	1.53e-05	0.000433	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.53e-05	0.000432	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	1.47e-05	0.000415	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—NAT2—systemic lupus erythematosus	1.4e-05	0.000397	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	1.4e-05	0.000395	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—RXRA—systemic lupus erythematosus	1.37e-05	0.000388	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.34e-05	0.00038	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.32e-05	0.000374	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.32e-05	0.000373	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.27e-05	0.00036	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.21e-05	0.000343	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.13e-05	0.000321	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.13e-05	0.000319	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	1.12e-05	0.000317	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.12e-05	0.000316	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PPARG—systemic lupus erythematosus	1.06e-05	0.000301	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—NAT2—systemic lupus erythematosus	1.06e-05	0.000299	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—RXRA—systemic lupus erythematosus	1.06e-05	0.000299	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	1.05e-05	0.000296	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1e-05	0.000284	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—ALB—systemic lupus erythematosus	9.57e-06	0.000271	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—NOS3—systemic lupus erythematosus	9.15e-06	0.000259	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—NAT2—systemic lupus erythematosus	8.95e-06	0.000253	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	8.77e-06	0.000248	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PPARG—systemic lupus erythematosus	8.65e-06	0.000245	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PTGS2—systemic lupus erythematosus	8.37e-06	0.000237	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	8.32e-06	0.000236	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—RXRA—systemic lupus erythematosus	7.87e-06	0.000223	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—ALB—systemic lupus erythematosus	7.78e-06	0.00022	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	7.62e-06	0.000216	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	7.48e-06	0.000212	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—NOS3—systemic lupus erythematosus	7.44e-06	0.000211	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	7.3e-06	0.000207	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	7.11e-06	0.000201	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—EP300—systemic lupus erythematosus	6.96e-06	0.000197	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	6.91e-06	0.000195	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PTGS2—systemic lupus erythematosus	6.8e-06	0.000193	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PPARG—systemic lupus erythematosus	6.67e-06	0.000189	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	6.55e-06	0.000185	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	6.39e-06	0.000181	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	6.28e-06	0.000178	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—ALB—systemic lupus erythematosus	5.99e-06	0.00017	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	5.92e-06	0.000168	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	5.87e-06	0.000166	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—NOS3—systemic lupus erythematosus	5.73e-06	0.000162	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—EP300—systemic lupus erythematosus	5.66e-06	0.00016	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	5.59e-06	0.000158	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	5.44e-06	0.000154	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PTGS2—systemic lupus erythematosus	5.24e-06	0.000148	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	5.02e-06	0.000142	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PPARG—systemic lupus erythematosus	4.97e-06	0.000141	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4.65e-06	0.000132	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—ALB—systemic lupus erythematosus	4.47e-06	0.000126	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—EP300—systemic lupus erythematosus	4.36e-06	0.000123	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—NOS3—systemic lupus erythematosus	4.27e-06	0.000121	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	3.97e-06	0.000112	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PTGS2—systemic lupus erythematosus	3.91e-06	0.000111	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	3.87e-06	0.00011	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	3.74e-06	0.000106	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	3.71e-06	0.000105	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—ALB—systemic lupus erythematosus	3.57e-06	0.000101	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	3.41e-06	9.66e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	3.36e-06	9.52e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	3.33e-06	9.43e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—EP300—systemic lupus erythematosus	3.25e-06	9.2e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	3.22e-06	9.1e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	3.19e-06	9.02e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	3.17e-06	8.96e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	3.12e-06	8.83e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	2.94e-06	8.32e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	2.92e-06	8.25e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	2.85e-06	8.06e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	2.72e-06	7.71e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—EP300—systemic lupus erythematosus	2.6e-06	7.35e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	2.49e-06	7.05e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	2.45e-06	6.92e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	2.44e-06	6.92e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	2.42e-06	6.86e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	2.2e-06	6.22e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	2.1e-06	5.95e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	2.07e-06	5.87e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	1.92e-06	5.44e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	1.6e-06	4.53e-05	CbGpPWpGaD
